Diagnosis and treatment of adult tumor patients with COVID-19.
10.3760/cma.j.cn112152-20230119-00036
- Collective Name:Expert Committee of Geriatric Cancer Prevention and Treatment of Chinese Society of Clinical Oncology
- Publication Type:Journal Article
- Keywords:
COVID-19;
Diagnosis;
Malignant tumor;
Treatment
- MeSH:
Humans;
Adult;
Aged;
COVID-19/diagnosis*;
Neoplasms/epidemiology*;
Incidence;
Disease Outbreaks;
Diagnosis, Differential;
COVID-19 Testing
- From:
Chinese Journal of Oncology
2023;45(3):191-202
- CountryChina
- Language:Chinese
-
Abstract:
After the first outbreak of corona virus disease 2019 (COVID-19) at the end of 2019, it has caused multiple rounds of transmission in many countries around the world. Cancer patients are mainly elderly people, and the immunosuppression state caused by the tumor itself and anti-tumor treatment, more accompanying underlying diseases, and more hospital environmental exposure leading to a higher incidence of COVID-19 infection. The proportion of severe cases after infection is high, and the mortality is high. Therefore, based on the domestic and foreign research and clinical practice, the Expert Committee of Geriatric Cancer Prevention and Treatment of Chinese Society of Clinical Oncology launched a discussion based on the characteristics of cancer patients, including the epidemiology, clinical manifestations, differential diagnosis, definition and risk factors of severe cases, diagnosis and treatment recommendations, recovery of anti-tumor treatment and vaccination recommendations. To provide the corresponding suggestions for the clinical diagnosis and treatment of such patients.
